跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
PANZYGA
Authorized
STANDARD
PANZYGA
octapharma pharmazeutika produktionsges m b h
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
658d265b4e163c5b
Company
octapharma pharmazeutika produktionsges m b h
Type
Standard
Approval Details
Approval Id
658d265b4e163c5b
Drug Approval Canada Name
PANZYGA
Product Name
PANZYGA
Status
Dormant
Status Date
2023-07-31
Original Market Date
2016-12-21
Din
02456087
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
80:04.00
Atc Original
J06BA02 IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASC. ADM.
Atc Name
j 06 ba 02
Aig Number
0106267005
Company Name
octapharma pharmazeutika produktionsges m b h
Company Address
Oberlaaer Strasse 235, Vienna, Vienne, Austria, 1100
Active Ingredients
IMMUNOGLOBULIN (HUMAN)
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
658d265b4e163c5b
Type
Standard
Back to Health Canada Approvals
PANZYGA - Health Canada Drug Approval Details